首页 | 本学科首页   官方微博 | 高级检索  
     

125Ⅰ粒子植入联合化疗治疗非小细胞肺癌疗效观察
引用本文:付吕平,刘卫红,冯巧荣,张晓瑞. 125Ⅰ粒子植入联合化疗治疗非小细胞肺癌疗效观察[J]. 标记免疫分析与临床, 2011, 18(3)
作者姓名:付吕平  刘卫红  冯巧荣  张晓瑞
作者单位:邯郸市中心医院CT介入中心;
摘    要:
探讨125I粒子联合化疗治疗非小细胞肺癌(NSCLC)的临床疗效。采用CT引导下肿瘤内植入125I粒子,3天后行长春瑞滨(NVB)和顺铂(DDP)静脉化疗,于2、4、6个月观察治疗效果(CR,PR,SD,PD)。结果表明125I粒子联合化疗组的有效率(CR+PR)分别为82.8%,90.6%,93.7%;单纯化疗组分别为44.3%,48.6%,52.9%,两组有显著性差异(P<0.05)。NSCLC行125I粒子联合化疗具有协同作用,有利于短期内减轻肿瘤负荷,提高肿瘤疗效。

关 键 词:非小细胞肺癌  125I粒子  化学疗法  长春瑞滨  顺铂  

Clinical Efficacy of Interstitial Implantation of 125I Seeds Combined with Chemotherapy in Patients with Non-small Cell Lung Carcinoma
FU Lv-ping,LIU Wei-hong,FENG Qiao-rong,ZHANG Xiao-rui. Clinical Efficacy of Interstitial Implantation of 125I Seeds Combined with Chemotherapy in Patients with Non-small Cell Lung Carcinoma[J]. Labeled Immunoassays and Clinical Medicine, 2011, 18(3)
Authors:FU Lv-ping  LIU Wei-hong  FENG Qiao-rong  ZHANG Xiao-rui
Affiliation:FU Lv-ping,LIU Wei-hong,FENG Qiao-rong,ZHANG Xiao-rui(CT Invasive Center of Handan Central Hospital,Handan 056001,China)
Abstract:
To evaluate the clinical efficacy of 125I seed implantation combined with chemotherapy in the treatment of patients with non-small cell lung carcinoma(NSCLC).The patients with NSCLC(n=64) were received interstitially 125I seed implantation by CT-guided,and then were treated with NVB and DDP after three days.In control group(n=70),the patients were only treated with NVB and DDP.The therapeutic efficacy was observed after two,four and six months.The results showed that the effective rates(CR+PR) after two,fou...
Keywords:Non-small cell lung cancer  125I seed  Chemotherapy  NVB  DDP  
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号